Delayed surgery for localised and metastatic renal cell carcinoma: a systematic review and meta-analysis for the COVID-19 pandemic
-
Published:2021-05-24
Issue:12
Volume:39
Page:4295-4303
-
ISSN:0724-4983
-
Container-title:World Journal of Urology
-
language:en
-
Short-container-title:World J Urol
Author:
Chan Vinson Wai-ShunORCID, Tan Wei Shen, Leow Jeffrey J., Tan Wei Phin, Ong William Lay Keat, Chiu Peter Ka-Fung, Gurung Pratik, Pirola Giacomo Maria, Orecchia Luca, Liew Matthew Ping Chao, Lee Hsiang-Ying, Wang Yuding, Chen I-Hsuan Alan, Castellani Daniele, Wroclawski Marcelo Langer, Mayor Nikhil, Sathianathen Niranjan J., Braga Isaac, Liu Zhenbang, Moon Dora, Tikkinen Kari, Kamat Ashish, Meng Max, Ficarra Vincenzo, Giannarini Gianluca, Teoh Jeremy Yuen-ChunORCID
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Andrews JR, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, Callstrom MR, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH (2019) Oncologic outcomes following Partial Nephrectomy and percutaneous Ablation for cT1 renal masses. Eur Urol 76(2):244–251. https://doi.org/10.1016/j.eururo.2019.04.026 2. Simone G, De Nunzio C, Ferriero M, Cindolo L, Brookman-May S, Papalia R, Sperduti I, Collura D, Leonardo C, Anceschi U, Tuderti G, Misuraca L, Dalpiaz O, Hatzl S, Lodde M, Trenti E, Pastore AL, Palleschi G, Lotrecchiano G, Salzano L, Carbone A, De Cobelli O, Tubaro A, Schips L, Zigeuner R, Tostain J, May M, Guaglianone S, Muto G, Gallucci M (2016) Trends in the use of partial nephrectomy for cT1 renal tumors: analysis of a 10-yr European multicenter dataset. Eur J Surg Oncol 42(11):1729–1735. https://doi.org/10.1016/j.ejso.2016.03.022 3. Méjean A, Ravaud A, Thezenas S, Colas S, Beauval J-B, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Beisland C, Aitchison M, Oudard S, Patard J-J, Theodore C, Chevreau C, Laguerre B, Hubert J, Gross-Goupil M, Bernhard J-C, Albiges L, Timsit M-O, Lebret T, Escudier B (2018) Sunitinib alone or after Nephrectomy in metastatic renal-cell carcinoma. N Engl J Med 379(5):417–427. https://doi.org/10.1056/NEJMoa1803675 4. Bex A, Mulders P, Jewett M, Wagstaff J, Van Thienen JV, Blank CU, Van Velthoven R, Del Pilar LM, Wood L, Van Melick HHE, Aarts MJ, Lattouf JB, Powles T, De Jong IJ, Rottey S, Tombal B, Marreaud S, Collette S, Collette L, Haanen J (2019) Comparison of immediate vs deferred cytoreductive Nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving Sunitinib: the SURTIME Randomized Clinical Trial. JAMA Oncol 5(2):164–170. https://doi.org/10.1001/jamaoncol.2018.5543 5. Teoh JY-C, Ong WLK, Gonzalez-Padilla D, Castellani D, Dubin JM, Esperto F, Campi R, Gudaru K, Talwar R, Okhunov Z, Ng C-F, Jain N, Gauhar V, Wong MC-S, Wroclawski ML, Tanidir Y, Rivas JG, Tiong H-Y, Loeb S, UroSoMe Working G (2020) A global survey on the impact of COVID-19 on urological services. Eur Urol 78(2):265–275. https://doi.org/10.1016/j.eururo.2020.05.025
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|